SPM4.0 · Autonomous Scanning Probe Microscopy for Life Sciences and Medicine powered by Artificial Intelligence

Lines connect the coordinator with its partners.

Project objective

Artificial Intelligence is pushing forward the Industrial Revolution 4.0, which is transforming many areas of Society, including Science and Technology. Nanoscopy, a recognized pillar of the research and manufacture of Nanotechnology-based products, is among the areas that more quickly is adopting Artificial Intelligence. Machine learning algorithms are being developed and integrated in microscopes for its autonomous operation and in software toolboxes for the automatic analysis of large volumes of microscopy data. Scanning Probe Microscopy is particularly active in this integration with a special focus in the Life Sciences and Medical fields. Scanning probe microscopes powered by machine learning are expected to enable the autonomous and label-free nanoscale structural and functional (mechanical and electric) imaging of living cells and functional biomolecules in their native conditions, something never achieved in nanoscopic imaging. The objective of the SPM4.0 Doctoral Network is to train a new generation of researchers in the science and technology of autonomous Scanning Probe Microscopes powered by Artificial Intelligence for applications in the Life Science and Medical fields. The researchers of the network will acquire a state-of-the-art multidisciplinary scientific training in advanced scanning probe microscopy and machine learning and in their biological and medical applications. In addition, they will receive training on complementary and transferable skills to increase their employability perspectives and to qualify them to access to responsibility job positions in the private and public sectors. The final aim is to promote the wide adoption of SPM4.0 technologies in public and private research centers and in industrial and metrology institutions and to explore new horizons in the Life Sciences and Medical sectors regarding label-free nanoscopic cell imaging, illness diagnosis, or drug nanocarrier development, consolidating Europe as world leader.

Original text from CORDIS.

Participants

• FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA · BarcelonaCoordinatorSpain
• AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS · MadridSpain
• BRUKER NANO GMBH · BerlinGermany
• CESKY METROLOGICKY INSTITUT · BRNOCzechia
• CHARITE - UNIVERSITAETSMEDIZIN BERLIN · BerlinGermany
• DATRIX SPA · MilanoItaly
• FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA · BARCELONASpain
• FUNDACION ESADE · BarcelonaSpain
• GOETEBORGS UNIVERSITET · GoeteborgSweden
• IFLAI AB · MölndalSweden
• POLITECNICO DI MILANO · MilanoItaly
• POLYPEPTIDE THERAPEUTIC SOLUTIONS SOCIEDAD LIMITADA · VALENCIASpain
• SORBONNE UNIVERSITE · ParisFrance
• ScixelSpain
• TECHNISCHE UNIVERSITAET DRESDEN · DresdenGermany
• THE HENRYK NIEWODNICZANSKI INSTITUTE OF NUCLEAR PHYSICS, POLISH ACADEMY OF SCIENCES · KRAKOWPoland
• THE UNIVERSITY OF SHEFFIELD · SHEFFIELDUnited Kingdom
• UNIVERSIDAD AUTONOMA DE MADRID · MadridSpain
• UNIVERSITAT AUTONOMA DE BARCELONA · Cerdanyola Del VallesSpain
• UNIVERSITAT DE BARCELONA · BarcelonaSpain
• UNIVERSITAT DE VALENCIA · ValenciaSpain
• VYSOKE UCENI TECHNICKE V BRNE · BRNO STREDCzechia

Links

• View on CORDIS
• DOI: 10.3030/101168976
• https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e51679f893&appId=PPGMS
• https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5181cbbe8&appId=PPGMS
• https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e52615fef4&appId=PPGMS
• https://spm40.eu/